(-0.04%) 5 243.25 points
(-0.01%) 39 557 points
(-0.11%) 18 276 points
(-0.01%) $79.11
(-0.80%) $2.36
(0.19%) $2 347.40
(0.34%) $28.54
(0.07%) $1 011.50
(0.06%) $0.927
(0.07%) $10.82
(0.07%) $0.797
(-0.24%) $91.38
Live Chart Being Loaded With Signals
Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein...
Stats | |
---|---|
Today's Volume | 1.24M |
Average Volume | 2.31M |
Market Cap | 1.44B |
EPS | HKD0 ( 2024-03-27 ) |
Next earnings date | ( HKD0 ) 2024-06-07 |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -3.64 |
ATR14 | HKD0.00600 (0.33%) |
Volume Correlation
Jacobio Pharmaceuticals Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Jacobio Pharmaceuticals Correlation - Currency/Commodity
Jacobio Pharmaceuticals Financials
Annual | 2023 |
Revenue: | HKD63.52M |
Gross Profit: | HKD3.20M (5.04 %) |
EPS: | HKD-0.460 |
FY | 2023 |
Revenue: | HKD63.52M |
Gross Profit: | HKD3.20M (5.04 %) |
EPS: | HKD-0.460 |
FY | 2022 |
Revenue: | HKD95.75M |
Gross Profit: | HKD12.63M (13.20 %) |
EPS: | HKD-0.500 |
FY | 2021 |
Revenue: | HKD152.81M |
Gross Profit: | HKD12.83M (8.40 %) |
EPS: | HKD-0.396 |
Financial Reports:
No articles found.
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein. It is also develops JAB-BX102, a humanized inhibitory antibody against human CD73 for the treatment of PD-1 resistant cancer; JAB-6343, an inhibitor that targets fibroblast growth factor receptor 4 for advanced hepatocellular carcinoma with FGF19 overexpression; JAB-2485, an aurora A kinase inhibitor for solid tumors; JAB-24114, a tumor metabolic pathway for the treatment of solid tumors; and JAB-BX300, a molecule antibody targeting RAS pathway to treat pancreatic and other solid tumors with KRAS mutations. The company has a strategic collaboration with AbbVie Ireland Unlimited Company to develop and commercialize SHP2 inhibitors. Jacobio Pharmaceuticals Co., Ltd. was incorporated in 2015 and is headquartered in Beijing, China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators